Evidence map›Paper›PMID 30814637›Full record

ArticleScientific reports2019

Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths.

William L Poehlman, James J Hsieh, F Alex Feltus

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

William L PoehlmanClemson University Department of Genetics & Biochemistry, Clemson, SC, USA.
James J HsiehMolecular Oncology, Department of Medicine, Siteman Cancer Center, Washington University, St Louis, MO, USA.ORCID 0000-0003-3595-0551
F Alex FeltusClemson University Department of Genetics & Biochemistry, Clemson, SC, USA. ffeltus@clemson.edu.
Clemson University · USMolecular Oncology (United States) · US

Funding

Genetic Loss-of-Function Studies of SETD2 in Kidney TumorigenesisR01CA223231 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHENG, EMILY H · 2018 to 2022
$2.7M
NCI NIH HHS R01 CA223231
6 · The paper itself

Abstract

Renal cell carcinoma (RCC) subtypes are characterized by distinct molecular profiles. Using RNA expression profiles from 1,009 RCC samples, we constructed a condition-annotated gene coexpression network (GCN). The RCC GCN contains binary gene coexpression relationships (edges) specific to conditions including RCC subtype and tumor stage. As an application of this resource, we discovered RCC GCN edges and modules that were associated with genetic lesions in known RCC driver genes, including VHL, a common initiating clear cell RCC (ccRCC) genetic lesion, and PBRM1 and BAP1 which are early genetic lesions in the Braided Cancer River Model (BCRM). Since ccRCC tumors with PBRM1 mutations respond to targeted therapy differently than tumors with BAP1 mutations, we focused on ccRCC-specific edges associated with tumors that exhibit alternate mutation profiles: VHL-PBRM1 or VHL-BAP1. We found specific blends molecular functions associated with these two mutation paths. Despite these mutation-associated edges having unique genes, they were enriched for the same immunological functions suggesting a convergent functional role for alternate gene sets consistent with the BCRM. The condition annotated RCC GCN described herein is a novel data mining resource for the assignment of polygenic biomarkers and their relationships to RCC tumors with specific molecular and mutational profiles.

Indexed as

CarcinogenesisCarcinoma, Renal CellDatasets as TopicDisease ProgressionDNA-Binding ProteinsGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansKidney NeoplasmsMutationNeoplasm StagingOncogene Proteins, FusionTranscription FactorsTranscriptomeTumor Suppressor ProteinsUbiquitin ThiolesteraseBAP1 protein, humanDNA-Binding ProteinsOncogene Proteins, FusionPBRM1 protein, humanTranscription FactorsTumor Suppressor ProteinsUbiquitin ThiolesteraseVHL protein, humanVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID30814637
PMCPMC6393532
OpenAlexW2916836301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.